Related Experiment Video

Updated: Apr 21, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Low-density lipoprotein cholesterol lowering therapies: what is on the horizon?

Ramprasad Gadi1, Vincent M Figueredo

  • 1aEinstein Institute for Heart and Vascular Health, Einstein Medical Center bJefferson Medical College, Philadelphia, Pennsylvania, USA.

Journal of Cardiovascular Medicine (Hagerstown, Md.)
|November 8, 2014
PubMed

Insights

New therapies are emerging to further lower low-density lipoprotein cholesterol (LDL-C) beyond statins, addressing residual cardiovascular disease (CVD) risk and statin intolerance. These novel agents offer alternative options for managing high cholesterol and preventing CVD events.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Lipid Metabolism

Background:

  • Elevated low-density lipoprotein cholesterol (LDL-C) is a primary risk factor for cardiovascular disease (CVD).
  • Statins are effective but leave a significant residual CVD risk and are not tolerated by all patients.
  • Need for novel therapies to further reduce LDL-C and manage atherosclerotic CVD.

Purpose of the Study:

  • To review novel therapeutic agents for lowering LDL-C.
  • To discuss agents targeting residual CVD risk and statin intolerance.

Main Methods:

  • Review of emerging LDL-C lowering therapies.
  • Discussion of antisense oligonucleotides, PCSK9 inhibitors, and MTP inhibitors.
  • Analysis of mechanism of action, pharmacokinetics, efficacy, and safety.

Main Results:

  • Novel agents offer additional LDL-C reduction beyond statins.
  • Antisense oligonucleotides, PCSK9 inhibitors, and MTP inhibitors represent distinct therapeutic classes.
  • Efficacy and safety profiles vary among these novel agents.

Conclusions:

  • Novel agents provide promising alternatives for managing hyperlipidemia and reducing CVD risk.
  • These therapies address unmet needs in patients with statin intolerance or residual risk.
  • Further research and clinical application of these agents are warranted.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.3K
Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

12.8K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
650
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
880
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
891
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
2.8K